Disseminated progression of glioblastoma after treatment with bevacizumab

OBJECTIVES: Reports of glioblastoma (GBM) progression following treatment with bevacizumab indicate that a subset of patients develop disseminated, often minimally enhancing tumors that differ from the typical pattern of focal recurrence. We have reviewed our institutional experience with bevacizuma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Neurol Neurosurg
Asıl Yazarlar: Bloch, Orin, Safaee, Michael, Sun, Matthew Z., Butowski, Nicholas A., McDermott, Michael W., Berger, Mitchel S., Aghi, Manish K., Parsa, Andrew T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5565209/
https://ncbi.nlm.nih.gov/pubmed/23706614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clineuro.2013.04.017
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller